The evaluation of vaccine-induced antibodies involves considering time for immune response, assessing antibody levels in groups, selecting high-quality test kits, differentiating between IgG and cellular immunity, and accounting for maternal antibodies. Practical challenges include standardizing test procedures, cost considerations, and the need for consistent sampling, which may not always be feasible due to resource constraints.